PT925789E - Es oculares utilizacao de azitromicina no tratamento topico de infecco - Google Patents

Es oculares utilizacao de azitromicina no tratamento topico de infecco

Info

Publication number
PT925789E
PT925789E PT98309274T PT98309274T PT925789E PT 925789 E PT925789 E PT 925789E PT 98309274 T PT98309274 T PT 98309274T PT 98309274 T PT98309274 T PT 98309274T PT 925789 E PT925789 E PT 925789E
Authority
PT
Portugal
Prior art keywords
azithromycin
treatment
infecco
topic
eye use
Prior art date
Application number
PT98309274T
Other languages
English (en)
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT925789(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT925789E publication Critical patent/PT925789E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
PT98309274T 1997-12-02 1998-11-12 Es oculares utilizacao de azitromicina no tratamento topico de infecco PT925789E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02

Publications (1)

Publication Number Publication Date
PT925789E true PT925789E (pt) 2004-10-29

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98309274T PT925789E (pt) 1997-12-02 1998-11-12 Es oculares utilizacao de azitromicina no tratamento topico de infecco

Country Status (11)

Country Link
EP (1) EP0925789B2 (pt)
JP (1) JPH11240838A (pt)
AT (1) ATE271390T1 (pt)
BR (1) BR9805318A (pt)
CA (1) CA2254682C (pt)
CY (1) CY1105482T1 (pt)
DE (1) DE69825128T3 (pt)
DK (1) DK0925789T4 (pt)
ES (1) ES2221127T5 (pt)
MX (1) MX232591B (pt)
PT (1) PT925789E (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr) 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1652851A1 (en) 2001-05-22 2006-05-03 Pfizer Products Inc. New crystal form of Azithromycin
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CA2547774A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2006004085A1 (ja) 2004-07-02 2006-01-12 Wakamoto Pharmaceutical Co., Ltd. アジスロマイシン含有水性医薬組成物及びその調製方法
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
EP0721324A1 (en) * 1993-10-01 1996-07-17 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
WO1996019489A1 (en) * 1994-12-19 1996-06-27 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
CN1225230C (zh) † 1995-06-07 2005-11-02 南方生物系统公司 高粘度液体受控输送体系

Also Published As

Publication number Publication date
ES2221127T5 (es) 2009-11-10
CY1105482T1 (el) 2010-04-28
ES2221127T3 (es) 2004-12-16
DK0925789T4 (da) 2009-07-13
EP0925789A1 (en) 1999-06-30
CA2254682C (en) 2003-07-08
BR9805318A (pt) 2000-04-11
CA2254682A1 (en) 1999-06-02
EP0925789B2 (en) 2009-06-17
DE69825128T3 (de) 2010-05-06
DE69825128D1 (de) 2004-08-26
MX232591B (es) 2005-12-02
JPH11240838A (ja) 1999-09-07
ATE271390T1 (de) 2004-08-15
DE69825128T2 (de) 2005-07-28
DK0925789T3 (da) 2004-10-25
EP0925789B1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
PT925789E (pt) Es oculares utilizacao de azitromicina no tratamento topico de infecco
PT1075837E (pt) Processo de preparacao de formulacoes aquosas para utilizacao oftalmicas
PE14199A1 (es) Agonistas de 5-ht1f
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
DE69716135T2 (de) In 6-position durch thio substituierte paclitaxele
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
HUP0002662A3 (en) Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
DE69600244T2 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
FR2731007B1 (fr) Composition de polyorganosiloxanes reticulables
DE69936052D1 (de) N1 modifizierte glycopeptide
ID25478A (id) Agonis 5-ht1f
BR9610382A (pt) Composição de tratamento do cableo
ATE241640T1 (de) Fusidinsäure-derivate
FR2718254B1 (fr) Lunettes, notamment de vue ou solaires, et monture s'y rapportant.
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR9611904A (pt) Dioxidos de ditiazol